Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 6;10(19):6636-6646.
doi: 10.12998/wjcc.v10.i19.6636.

Giant retroperitoneal liposarcoma treated with radical conservative surgery: A case report and review of literature

Affiliations
Case Reports

Giant retroperitoneal liposarcoma treated with radical conservative surgery: A case report and review of literature

Eva Lieto et al. World J Clin Cases. .

Abstract

Background: Retroperitoneal liposarcoma (RLPS) is a rare malignant tumor of the connective tissue and usually grows to a large size, undetected. Diagnosis is currently based on collective findings from clinical examinations and computed tomography (CT) and magnetic resonance imaging, the latter of which show a fat density mass and possible surrounding organ involvement. Surgical resection is the main therapeutic strategy. The efficacy and safety of further therapeutic choices, such as chemotherapy and radiotherapy, are still controversial.

Case summary: A 61-year-old man presented with complaint of a large left inguinal mass that had appeared suddenly, after a slight exertion. Ultrasonography revealed an omental inguinal hernia. During further clinical examination, an enormous palpable abdominal mass, continuing from the left inguinal location, was observed. CT revealed a giant RLPS, with remarkable mass effect and wide visceral dislocation. After multidisciplinary consultation, surgical intervention was performed. Subsequent neoadjuvant chemotherapy and radiotherapy were precluded by the mass' large size and retroperitoneal localization, features typically associated with non-response to these types of treatment. Instead, the patient underwent conservative treatment via radical surgical excision. After 1 year, his clinical condition remained good, with no radiological signs of recurrence.

Conclusion: Conservative treatment via surgery resulted in a successful outcome for a large RLPS.

Keywords: Case report; Differentiated liposarcoma; Giant sarcoma; Retroperitoneal liposarcoma; Retroperitoneal sarcoma surgical outcome; Sarcoma diagnosis; Sarcoma surgical treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Preoperative image and computed tomography scan. A: Preoperative image, the patient was initially diagnosed with a left inguinal hernia; B: Preoperative computed tomography scan. A giant retroperitoneal liposarcoma occupied the entire left abdominal cavity with extreme lateralization of the bowel and the left kidney. A grade III hydronephrosis was evident.
Figure 2
Figure 2
Surgical specimen. A completely encapsulated liposarcoma was entirely removed without any surrounding organ damage.
Figure 3
Figure 3
Postoperative computed tomography scan. The intra-abdominal organs resumed their physiological positions. A: Computed tomography (CT) scan at the level of the celiac trunk; B: CT scan at the level of the left renal vein.
Figure 4
Figure 4
Pathologic picture of well-differentiated liposarcoma. A: Atypical stromal cells (black arrows; mandatory for diagnosis of well-differentiated liposarcoma) and collagen ropey bands (blue arrow; enhance diagnostic confidence) are present; B: Lipoblastic cell (green arrow).

Similar articles

Cited by

References

    1. Hazen B, Cocieru A. Giant Retroperitoneal Sarcoma. J Gastrointest Surg. 2017;21:602–603. - PubMed
    1. Peterson JJ, Kransdorf MJ, Bancroft LW, O'Connor MI. Malignant fatty tumors: classification, clinical course, imaging appearance and treatment. Skeletal Radiol. 2003;32:493–503. - PubMed
    1. Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives. Pathologica. 2021;113:70–84. - PMC - PubMed
    1. von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Keedy V, Kim E, Koon H, Mayerson J, McCarter M, McGarry SV, Meyer C, Morris ZS, O'Donnell RJ, Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Ruo B, Schuetze S, Tap WD, Wayne JD, Bergman MA, Scavone JL. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16:536–563. - PubMed
    1. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. Editors. WHO Classification of Soft Tissue and Bone. Switzerland: WHO, 2013.

Publication types